pep stock in crisis: GLP-1 drugs reshape US carts and push PepsiCo turnaround 3 years late
PepsiCo’s Q3 2026 earnings miss shows GLP-1 weight loss drugs are structurally cutting demand for salty snacks and sugary drinks. Higher North American costs and...
